The authors revealed that the activation of estrogen receptor ERα by BP-1 initiates crosstalk between ERα and the Wnt/β-catenin pathway, resulting in aberrant stimulation and progression of SKOV-3 cancer cells. This evidence concerns the gene ESR1 and cancer.